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ABSTRACT
Correction of a defective gene is a promising
approach for both basic research and clinical gene
therapy. However, the absence of site-specific tar-
geting and the low efficiency of homologous recom-
bination in human cells present barriers to
successful gene targeting. In an effort to overcome
these barriers, we utilized triplex-forming oligo-
nucleotides (TFOs) conjugated to a DNA interstrand
crosslinking (ICL) agent, psoralen (pTFO-ICLs), to
improve the gene targeting efficiency at a specific
site in DNA. Gene targeting events were monitored
by the correction of a deletion on a recipient plasmid
with the homologous sequence from a donor
plasmid in human cells. The mechanism underlying
this event is stimulation of homologous recombina-
tion by the pTFO-ICL. We found that pTFO-ICLs are
efficient in inducing targeted gene conversion (GC)
events in human cells. The deletion size in the recip-
ient plasmid influenced both the recombination
frequency and spectrum of recombinants; i.e.
plasmids with smaller deletions had a higher fre-
quency and proportion of GC events. The polarity
of the pTFO-ICL also had a prominent effect on
recombination. Our results suggest that pTFO-ICL
induced intermolecular recombination provides an
efficient method for targeted gene correction in
mammalian cells.
INTRODUCTION
One approach to gene therapy is to replace defective
genes with wild-type functional genes at a targeted site
in the genome (1). This approach has the advantage of
ensuring gene expression at endogenous levels under the
physiological control of normal gene regulatory elements.
To achieve site-speciﬁc gene correction, an homologous
sequence containing the wild-type gene serving as a
template is required. Another requirement is the use of a
strategy to eﬃciently direct the homologous sequence to
the targeted site in the genome. Enhancing homologous
recombination (HR) provides one such strategy; however,
the frequency of targeted HR in mammalian cells is
roughly two to three orders of magnitude lower than
random integration (2). To address this issue, we have
employed triplex technology to enhance the frequency of
HR in mammalian cells. Triplex-forming oligonucleotides
(TFOs) are small single-stranded oligonucleotides that can
bind speciﬁcally to the purine-rich strand of a target
duplex DNA (3,4). TFOs have been used to increase the
level of HR at speciﬁc sites by forming a triplex structure
at the targeted site (5–7). However, conjugation of a DNA
damaging reagent such as psoralen to the TFO can further
enhance its ability to stimulate HR (5,7,8).
Psoralens are naturally occurring planar tri-heterocyclic
compounds consisting of a furan ring and a pyrone ring.
Psoralen can intercalate in DNA, and upon irradiation by
UVA light (365nm), psoralen can form a monoadduct
with a pyrimidine base on either the furan side or the
pyrone side (9); furan-sided monoadducts are readily con-
verted into interstrand crosslinks (ICLs) by absorption of
a second photon at 365nm. The psoralen ICL is asymmet-
ric, and the repair of psoralen ICLs is also asymmetric
with a preference for incision on the furan side of the
ICL (10,11). The preferred psoralen crosslinking site is a
50TpA-30 sequence; however psoralen binds/intercalates
DNA with little sequence speciﬁcity. TFOs conjugated
to psoralen can be used to target psoralen to speciﬁc
sites in the genome, thereby directing the formation of
site-speciﬁc ICLs. Previous studies have demonstrated
that TFO-directed psoralen ICLs (pTFO-ICLs) can
induce HR between two direct repeats, which results
from an HR sub-pathway, single-strand annealing (SSA)
(5,6,8,12). However, in typical gene therapy applications,
intermolecular HR (HR between two DNA molecules) is
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pTFO-ICLs to enhance intermolecular HR. We measured
the HR frequencies induced by pTFO-ICLs at targeted
sites, and characterized the factors involved, such as the
eﬀect of polarity of the pTFO-ICL and the degree of
homology between the two DNA molecules on HR
frequencies and spectra. We constructed a series of
plasmid substrates with diﬀerent deletion sizes in the
supF reporter gene with the TFO binding site in both
orientations relative to the targeted supF gene. Our
results demonstrate that the pTFO-ICL induced
signiﬁcantly higher levels of targeted intermolecular HR
in a plasmid substrate containing a small deletion (4bp),
but not in plasmids containing a larger deletion (24bp).
This eﬀect depended on the polarity of the TFO relative to
the targeted supF gene, with a higher frequency of HR on
those plasmids with the ICL located further, as opposed
to nearer, the supF gene target. Analysis of recombinant
spectra revealed that targeted gene correction was
predominant only with substrates containing the short
(4bp) deletion.
MATERIALS AND METHODS
Plasmid constructions
The shuttle vector, pSupFG1, was modiﬁed to generate
two types of recipient plasmids serving as target
substrates, as shown in Figure 1A: one set of plasmids
contained a small deletion (4bp) within the supF target
gene at the BsrBI restriction site (original position
37–41bp); the second group of plasmids contained a
larger (24bp) deletion within the targeted supF gene,
from the XhoI restriction site to the BsrBI restriction
site (original position 17–41bp). In all plasmids, a 60bp
DNA linker sequence containing a pTFO1 (psoralen-50-T
GTGGTGGGGGGTTTGGGG-30) binding site was
inserted after an EagI restriction site (original position
124bp; Figure 1C). The pTFO1 binding site was inserted
in both orientations relative to the targeted supF gene,
i.e. such that the TFO-directed ICL is at the same
distance from the supF gene, but the TFO target duplex
sequence is either closer to or further from the supF
gene (Figure 1A). The plasmid substrates were
conﬁrmed by DNA sequencing. All these substrate
plasmids produce white colonies in MBM7070 indicator
Escherichia coli when grown on X-Gal, IPTG, ampicillin
(XIA) plates.
The donor plasmid, p1.2kHD, contains a 1.2kb frag-
ment homologous to a region in the pSupFG1 plasmid
containing the wild-type supF gene. This plasmid was con-
structed by digesting pSupFG1 with EcoRI and EcoO109I
restriction enzymes. The 2.5kb donor plasmid backbone
was obtained from the pEGFP-C1 plasmid (Clontech) by
digestion with EcoO109I and EcoRI. Ligation of these
two fragments yielded the donor plasmid, p1.2kHD.
This plasmid contains two unique restriction enzyme
sites, BsaAI and Bsu36I (Figure 1B), which are absent
from the substrate/recipient plasmids. These sites are
used to digest and eliminate the donor plasmid; following
co-transfection of both substrate and donor plasmids
into HeLa cells, the recovered plasmids were digested
with these two restriction enzymes prior to plasmid trans-
formation of the indicator bacterial strain MBM7070 to
eliminate the donor plasmid, thereby avoiding any HR
events generated in the indicator bacteria.
Substrate preparation
Duplex plasmid substrates (‘Dup’) are the original
plasmids described above, in the absence of any treatment.
UVA-treated plasmids (‘UVA’) were the duplex plasmid
substrates irradiated with 1.8J/cm
2 of UVA (at 365nm).
Triplex plasmids (‘Triplex’) are the duplex plasmids
(1.5mg) incubated with pTFO1 (50-psoralen-TGTGGTG
GGGGGTTTGGGG-30)( 1 ml of TFO at 1.2 10
4M) in
triplex binding buﬀer [TBB: 10mM Tris–HCl, pH 7.6,
10mM MgCl2 and 10% (vol/vol) glycerol] in a total
volume of 50mla t3 7  C overnight, without UVA irradia-
tion. The TFO-directed psoralen ICL-containing plasmids
(‘pTFO-ICL’) are the duplex plasmid substrates incubated
with pTFO1 under the same conditions as the ‘Triplex’
plasmids except that these plasmids were irradiated with
1.8J/cm
2 UVA light (365nm) to generate the ICL. The
ICL-only plasmid (‘ICL’) is the duplex plasmid treated
in a similar fashion as ‘pTFO-ICL’ plasmid, but with
the TFO removed, leaving only the site-speciﬁc ICL.
To prepare this plasmid substrate, we used a TFO, p-ss-
TFO1, which has the psoralen tethered to the 50-end of
TFO1 via a disulphide linker. After overnight incubation
and UVA irradiation to crosslink the psoralen to the
duplex target, 10mM DTT was added to the reaction,
and the reaction was further incubated at 65 C for 6h
to detach the TFO, as we have previously described (13).
BglII and SalI digestion can be used to verify the removal
of the TFO and the presence of the ICL, respectively
(Figures 1C and 2). Samples were covered with Mylar
ﬁlm during UVA irradiation, which eﬀectively eliminates
UV with wavelengths <320nm. The pBsr-R ‘DSB’
plasmid substrate was prepared by co-digesting the
plasmid with EcoRV and SalI enzymes to produce a
DNA double-strand break (DSB) with no homology at
the ends.
Recombination assays
Approximately 5 10
5 HeLa cells were seeded in T-25
ﬂasks 24h prior to transfection with reporter plasmids.
The cells were transfected with a plasmid mixture contain-
ing 1.5mg substrate plasmid and 4.5mg donor plasmid
( 1:4 molar ratio) using Geneporter transfection
reagent, according to the manufacturer’s instructions
(Genlantis, San Diego, CA, USA). The next day, the
cells were washed twice with PBS, and incubated in
5ml EMEM culture medium containing 10% FBS,
2mML-glutamine, and 1% Pen-strep antibiotics. The
cells were cultured in 5% CO2 at 37 C for another 48h.
Seventy-two hours after transfection, cells were harvested
with trypsin–EDTA followed by centrifugation at
1000r.p.m. at 4 C for 5min. After one wash with PBS,
the cell pellets were lysed and the plasmid DNA was
isolated with Qiagen Miniprep kit (Qiagen, Valencia,
CA, USA), extracted twice with phenol/chloroform/
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The dried plasmid DNA was dissolved in 60ml ddH2O
and passed through a G25 column by spinning at
3500r.p.m. for 2min to remove any residual salt.
Finally, 7ml of NEB buﬀer 3, 0.7ml BSA and 1ml each
of DpnI, BsaAI and Bsu36I were added to the ﬂow-
through (ﬁnal volume 70ml) and incubated at 37 C for
6h. The plasmid DNA was then re-extracted from the
digestion reaction with phenol/chloroform/isoamyl
alcohol (25:24:1). After washing twice with 75%
ethanol and drying the plasmid, the DNA was dissolved
in 10ml ddH2O. Next, 3ml of plasmid DNA was used
to transform competent MBM7070 indicator bacteria
with the Gene Pulser apparatus (BioRad, Hercules, CA,
USA), followed by suspension in 500ml SOC media and
incubation at 37 C on a shaker for 45min. Finally, the
bacterial cells were spread on LB plates containing XIA
medium for blue-white colony screening as we have
previously described (8).
Characterization of recombinants
The recombinant (blue) colonies were picked and streaked
onto another LB plate prior to performing colony PCR
for analysis of recombinant structures. The primer
sequences used for DNA structure analysis of recom-
binant plasmids were: 50-ATAATACCGCGCCACATA
GC-30 (upstream), and 50-GCCTACATACCTCGCTCT
GC-30 (downstream). PCR reaction conditions consisted
of denaturing at 90 C, annealing at 54.7 C and elongation
at 72 C. After 35 cycles, the PCR products were digested
with the BsrBI restriction enzyme (0.5ml of BsrBI in a
15ml reaction volume) for 3h at 37 C. Then the samples
were loaded onto a 1% agarose gel and electrophoresed at
80V for 2h. Finally, the gel was visualized by EtBr
staining. The colonies showing an abnormal restriction
digestion proﬁle compared to wild-type pSupFG1
plasmid were re-streaked and a second conﬁrmative
PCR and BsrBI digestion was performed. In addition,
Figure 1. Schematic of recipient (A) and donor (B) plasmids. (A) Psoralen ICL sites are at the same position in all plasmids, the dashed line indicates
the purine-rich strand bound by pTFO1. This TFO binding sequence was inserted in the plasmids via an insertion of 73bp shown in (C). (B) The
donor plasmid, p1.2kHD, has a 1.2kb fragment homologous to the recipient plasmids, but contains the wild-type supF gene. p1.2kHD has two
restriction enzyme sites for BsaAI and Bsu36I, which are absent from the recipient plasmids. (C) The insertion sequence containing the TFO1 binding
sequence. The unique SalI site is used to conﬁrm the presence of the ICL, and the unique BglII site is used to conﬁrm the presence of the triplex
structure formed by TFO binding.
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standard DNA sequencing methods.
Statistical analysis
The signiﬁcance of the diﬀerences in homologous recom-
bination frequencies between groups was conducted by
using Student’s t-test. To analyze the diﬀerences in
recombinant spectra, we utilized the pair-wise propor-
tional test.
RESULTS
TFO-directed psoralen ICLs stimulate intermolecular HR
The recipient plasmid, pBsr-R, was subjected to treatment
with a psoralen-conjugated TFO (pTFO) and UVA irra-
diation to measure enhancement of HR by site-speciﬁc
pTFO-ICL damage. In addition, other treatments repre-
senting various controls included UVA irradiation only,
pTFO treatment only (no ICL), removal of the TFO from
the pTFO-psoralen/UVA-irradiated substrate (ICL only),
and restriction enzyme digestion to generate a DSB, all as
described in ‘Materials and Methods’ section. The recom-
bination frequency was determined as the number of blue
colonies/(total number of white+blue colonies). Blue
colonies can result from both homologous recombination
and illegitimate recombination (as discussed below). The
duplex plasmid (Dup) without any treatment served as a
negative control. As shown in Figure 3, the pTFO-ICL
induced a signiﬁcantly higher recombination frequency
(27.2 10
4,  6-fold above background) than background
(Dup, 4.7 10
4), UVA irradiated plasmid only (UVA,
3.7 10
4, near background levels), triplex structure only
(Triplex, 4.2 10
4, near background levels) or the ICL
only (ICL, 9.4 10
4,  2-fold above background). The
plasmid containing the DSB served as a positive control,
and as expected, stimulated recombination (57.2 10
4,
 12-fold above background) more than any other treat-
ment. Although the ICL alone induced a higher HR fre-
quency (9.4 10
4) than Dup (4.7 10
4), UVA (3.7 10
4)
and Triplex (4.2 10
4) plasmid substrates, there were no
signiﬁcant diﬀerences among these treatments (Figure 3).
Colony PCR and BsrBI digestion conﬁrm pTFO-ICL-
induced targeted gene conversions
The recombinant spectra were analyzed by colony PCR
plus BsrBI digestion. The BsrBI restriction site is unique in
the parental pSupFG1 plasmid. This site was eliminated
during the construction of recipient plasmids. If the recip-
ient plasmid underwent targeted gene conversion within
the mutant supF gene, then the restored wild-type supF
gene should have a BsrBI site such that a PCR product
could be cut into two fragments with lengths of 325bp and
594bp (Figure 4). Figure 4 shows representative examples
of colony PCR plus BsrBI digestion from pBsr-R plasmids
with diﬀerent treatments. The summarized data are shown
in Table 1. The major recombination products of Dup,
UVA, ICL and pTFO-ICL plasmid substrates were gene
conversions (at least 72%), but the pTFO-ICL plasmid
showed the highest GC frequency among all these
treatments (Figure 3), indicating that the pTFO-ICL
is eﬀective in inducing both high GC frequency and high
GC proportion. In contrast, most recombination products
from Triplex and DSB plasmid substrates resulted from
illegitimate recombination events (at least 50%).
The size of the deletion in the supF gene aﬀects pTFO-
ICL-induced gene conversion frequency and spectrum
To investigate the eﬀect of deletion size on pTFO-ICL-
induced HR, we used plasmids with diﬀerent sizes of
deletions in the supF gene. In plasmids with the same
polarity of the pTFO-ICL, the pTFO-ICL induced
signiﬁcantly higher HR frequencies in the plasmids con-
taining the smaller deletion (Figure 5). pTFO-ICL-
induced HR frequency in pBsr-R was 27.2 10
4, which
was  11-fold higher than that in pXB-R (2.3 10
4).
Statistical analysis demonstrated a signiﬁcant diﬀerence
between them (P<5 10
5). Similarly, pTFO-ICL-
induced HR frequency in the pBsr plasmid (11 10
4)
was  4-fold higher than that of the pXB plasmid
(2.4 10
4), which is also signiﬁcant (P<0.005).
In addition to the impact on HR frequency, deletion
size also aﬀected the HR spectrum induced by a pTFO-
ICL. Figure 6 and Table 2 demonstrate that the major
products in plasmids with the smaller 4bp deletion
(pBsr-R and pBsr) were targeted GC events ( 87% in
pBsr-R and  67% in pBsr). In contrast, illegitimate
recombinants were the major product (>90%) in
plasmids containing the larger 24bp deletions (pXB-R
and pXB). Statistical analysis showed that there was a
signiﬁcant diﬀerence (P<5 10
6) between plasmids with
smaller deletions (4bp) versus larger deletions (24bp) in
pTFO-ICL treatment groups, regardless of the polarity of
the pTFO-ICL.
To conﬁrm recombinant spectra, we re-streaked those
blue colonies with abnormal patterns of colony PCR and
BsrBI digestion. The results conﬁrmed the presence of an
abnormal proﬁle from these blue colonies. Furthermore,
we isolated the plasmid DNA from these abnormal
colonies and subjected them to DNA sequencing and
BsrBI digestion. Results of sequencing indicated the
presence of a wild-type supF gene in some recombinants
(in addition to inserted sequences). Although some of the
Figure 2. Enzyme digestion to conﬁrm the plasmid substrate contain-
ing an ICL. Lanes 1, 4, 7: supercoiled plasmids with no treatment; lanes
2, 5, 8: plasmids treated with SalI; lanes 3, 6, 9: plasmids treated with
BglII. Duplex plasmid can be cut by both SalI and BglII (lanes 2 and
3), but the plasmid with the p-ss-TFO-ICL is resistant to both SalI and
BglII digestion (lanes 5 and 6). However, if a plasmid containing a p-ss-
TFO-ICL is treated with DTT, the plasmid can be cut by BglII
(linearized band in Lane 9), but not by the SalI enzyme (Lane 8).
This indicated that TFO1 had been removed by DTT treatment and
the psoralen ICL was still present at the SalI restriction site.
Nucleic Acids Research, 2009,Vol.37, No. 19 6381Figure 4. Recombination spectrum analysis by colony PCR plus BsrBI digestion shows the diﬀerent eﬀects of the various treatments on the
recombination spectrum.
Figure 3. pTFO-ICL treatment can stimulate intermolecular recombination. All results are from three independent experiments (error bars represent
the SD), P-values were derived from Student’s t-test. Diﬀerent treatments are illustrated below the bars.
6382 Nucleic Acids Research, 2009,Vol.37, No. 19recombinants did not contain a wild-type supF gene in the
sequenced regions, BsrBI digestion linearized all of these
the plasmids, indicating the presence of wild-type supF
gene within the plasmids, but beyond the sequenced
region (Figure 7).
pTFO-ICL polarity aﬀects the recombination frequency
In plasmid substrates with small deletions (4bp), the
recombination frequency in pBsr-R with pTFO-ICL treat-
ment was higher than that of pBsr (P<0.05) (Figure 5).
The psoralen ICLs in these two plasmids were located the
same distance from the supF gene. The only diﬀerence was
the polarity of triplex structure relative to the supF gene.
The position of the pTFO-ICL in pBsr-R had the TFO
binding site located further from the supF gene, while the
TFO binding site was nearer to the supF gene in plasmid
pBsr, as shown in Figure 1A. Although the pTFO-ICL
induced a higher frequency of GC in pBsr-R (Figure 5),
the proportion of GC events between these two plasmids
was not signiﬁcantly diﬀerent (Table 2; P=0.22). For
those plasmids containing the larger deletions (24bp),
pXB-R and pXB, both recombination frequencies and
spectra were very similar and no signiﬁcant diﬀerences
were detected regardless of the pTFO-ICL polarity.
Therefore, the eﬀect of pTFO-ICL polarity on GC fre-
quency and spectrum depends on the deletion size in the
homologous region of the recipient plasmid.
DISCUSSION
This study was undertaken to examine the eﬀects of
the positioning of a pTFO-ICL lesion on induced
Table 1. Intermolecular recombination events in plasmid pBsr-R
Figure 5. The eﬀects of target gene deletion size on pTFO-ICL-induced intermolecular recombination frequency. All results are from three inde-
pendent experiments (error bars represent the SD), P-values were derived from Student’s t-test. Diﬀerent treatments are illustrated below the bars.
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cells; in addition, we wished to determine how other
parameters such as whether the removal of the TFO
from the pTFO-ICL and the size of deletions in the
homologous target inﬂuenced HR incited by site-speciﬁc
DNA damage. Results presented here support our
previous conclusion that eﬃcient site-speciﬁc induction
of homologous recombination requires both the TFO-
induced triplex structure and the psoralen ICL (8).
Although plasmids containing only the ICL or the
pTFO-ICL have the psoralen ICL structure in common,
the presence of the triplex structure in the pTFO-ICL was
observed to signiﬁcantly stimulate HR. However, the
triplex structure alone (in the absence of the psoralen
ICL) induced HR only slightly above background levels
(Figure 3), similar to the function of the triplex structure
in SSA (6,8). There is the possibility that the TFO (in the
absence of the covalent psoralen–DNA linkage) might
be displaced from its target site during recombination in
these substrates. However, if this were indeed the case,
then the TFO only plasmid should have the same recom-
bination frequency and spectrum as the untreated
(Dup) plasmid. While the recombination frequencies
between Dup and Triplex plasmids are very similar, the
Figure 6. The eﬀects of target gene deletion size on pTFO-ICL-induced intermolecular recombination spectrum. Representative samples of colony
PCR plus BsrBI digestion demonstrate the eﬀects of deletion sizes on the recombination spectrum.
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and Table 1, P<0.0005). Therefore, the triplex structure
is likely present on the substrate in the cells, but the
processing of the triplex structure in the absence of the
ICL may diﬀer from that of the pTFO-ICL. In support
of this interpretation, it has been shown that triplex-
induced HR requires functional XPA, and the triplex
alone is not as eﬃcient as the pTFO-ICL in inducing
SSA, suggesting diﬀerent pathway utilization in pro-
cessing these two lesions (6,14). Psoralen ICLs in the
absence of the triplex structure may be primarily
repaired by a dual incisions around the ICL on the
purine-rich strand, which would displace the strand con-
taining the psoralen adduct, producing a single-strand gap
that could be bypassed by translesion synthesis poly-
merases (6,12,15–17). However, some of the intermediate
Table 2. Eﬀects of deletion size and ICL polarity on HR
Figure 7. Conﬁrmation of the presence of a wild-type supF gene in plasmids with aberrant colony PCR plus BsrBI digestion proﬁles. SC: supercoiled
plasmid. L, BsrBI linearized plasmid. The plasmids with (L) or without (SC) BsrB1 treatment are shown.
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HR pathway to yield targeted GC products.
The triplex structure may also recruit certain repair
proteins more eﬃciently than the psoralen ICL alone,
such as the MMR repair protein complex MSH2–MSH3
(MutSb) (18,19). MSH2 is required for the eﬃcient pro-
cessing of TFO-directed psoralen ICLs, but not for pTFO-
ICL-induced mutagenesis (20), suggesting that MSH2
might channel the psoralen ICL into a more error-free
pathway (i.e. HR). In fact, MutSb deﬁciency can lead to
reduced levels of HR (21).
Our analysis of recombinant structures conﬁrms that
targeted gene conversions are eﬃciently induced by
TFO-ICLs. The signiﬁcantly lower proportion of
targeted GC events in the Triplex plasmid substrate
compared with the pTFO-ICL containing plasmids
might also be explained by diﬀerent repair proteins or
pathways being involved. As noted above, MMR
proteins could play a role in pTFO-ICL repair
(18–20,22). Since MMR can inhibit non-homologous
recombination (23–26), the recombination events in the
plasmids containing the pTFO-ICL may shift toward
targeted homologous GC.
As a positive control for inducing HR, we included
recipient plasmids containing a DSB in our studies.
Although, as expected, the DSB containing recipient
plasmid induced the highest recombination frequency
among all the treatment groups (Figure 3),  50% of the
recombinants were the result of illegitimate recombination
(Table 1). The GC proportion from DSBs is signiﬁcantly
lower than that from pTFO-ICL treatment (P<0.0005).
This result is consistent with a previous report that  70%
of recombination products are generated by illegitimate
recombination (27), indicating that DSB repair in mam-
malian cells occurs predominantly via a non-homologous
end joining mechanism (28,29). The recombination
spectra diﬀered between the plasmids containing a DSB
and those containing a pTFO-ICL, which also implies that
each is subject to diﬀerent repair processing. On the other
hand, although previous reports have demonstrated that
DSB formation occurs during psoralen ICL processing
(30–35), all the plasmid substrates containing psoralen
ICLs may not be converted into DSB intermediates.
Several proposed ICL repair models imply the presence
of intermediate products with a single-stranded gap and
an oligonucleotide ﬂap containing the psoralen ICL
(12,36–39). If a homologous sequence is available, the
30-OH end of the single-stranded gap may be able to
initiate HR via a synthesis-dependent strand annealing
(SDSA) mechanism (40–42).
The data presented in this study are the ﬁrst to demon-
strate a signiﬁcant enhancement of induced HR between
two DNA plasmids in mammalian cells by pTFO-ICLs,
when the donor sequence is presented on a replicating
plasmid. Previous studies on pTFO-ICLs used TFOs
tethered to donor oligonucleotides (43–45) or non-
replicating donor plasmids (27), which induced only low
levels of HR. In this latter study, although the donor
sequence was presented in an SV40-derived shuttle
vector, the lymphoblastoid cells used could not support
plasmid replication and the length of homology was
only about 180bp (27). In our study, the donor plasmid
and cell line (HeLa) supported replication, which could
generate more donor plasmids for HR. Another important
factor is the length of the homologous sequence between
the donor and recipient plasmids. In our donor plasmid,
the homologous sequence length between recipient
and donor plasmids is about 1.2kb, whereas in these
previously reported experiments, the homologous
sequences were <300bp (27,43–45). Longer homologous
sequences could be important in stimulating HR, since
there is a minimum requirement of homology for stable
heteroduplex formation (46–49).
In our previously reported results (8) we observed that
for intramolecular recombination, gene conversions
induced by TFO-directed psoralen crosslinks occurred
preferentially at smaller (8bp) as opposed to larger
(24bp) deletions in the supF gene. In the results reported
here for intermolecular recombination, we varied the size
of the deletion (4bp versus 24bp) in the target plasmid to
assess what eﬀect target deletion size has on pTFO-ICL
induced gene conversion in this system. As shown in
Figure 5, target plasmids with the smaller, 4bp deletion
(pBsr-R and pBsr) exhibited signiﬁcantly higher levels of
induced recombination than those with the larger, 24bp
deletion (pXB-R and pXB). Results presented in Table 2
clearly indicates that plasmids pBsr-R and pBsr are more
readily converted than pXB-R and pXB plasmids, and
that this is the case regardless of whether or not recombi-
nation is induced by TFO-directed psoralen ICLs. Thus,
pTFO-ICL induced frequencies, but not the recombinant
spectra, are apparently inﬂuenced by the size of the target
deletion. There is signiﬁcant sequence heterology in the
immediate vicinity of the supF target in all these
plasmids. This heterology is the result of the diﬀerences
in the sizes of the deletions, as well as to an insertion of
60bp containing the pTFO binding site which is present in
the target, but not the donor plasmid. This may result in
less stable heteroduplex formation than in the completely
homologous sequences downstream from the supF target,
and could explain why shorter conversion tracts may be
more productive in generating functional recombinants.
The recombinants resulting from pTFO-ICL treatment
of the 4bp deletion target plasmids, pBsr-R or pBsr,
may have been generated from DSB intermediates
(30–35,50,51), from single-stranded gap intermediates
(12,36–39), or from both. The triplex structure is resistant
to DNA endonuclease digestion in vitro (52); thus, we
postulate that DSBs might form in vivo only on the side
of the psoralen ICL away from the triplex structure. In
pBsr-R containing the pTFO-ICL, a ‘clean’ DSB may
form downstream, but proximal, to the supF gene with
the pTFO-ICL remaining on the side of the DSB distal
to supF. On the other hand, for the pBsr plasmid contain-
ing a pTFO-ICL, the ‘dirty’ end (containing the pTFO-
ICL) is located proximal to the supF gene, and the DSB is
downstream. The ‘clean’ DSB can be used to initiate HR
directly, but the ‘dirty’ end must be further processed to
initiate HR, because only the DSB end without an ICL
could be used to invade the homologous sequence on the
donor DNA template (37). Therefore, in plasmid pBsr
containing a pTFO-ICL, HR may be mainly initiated
6386 Nucleic Acids Research, 2009,Vol.37, No. 19from a single-stranded gap intermediate after unhooking
the psoralen from the purine-rich strand of the duplex
(6,12,13,15–17). The 30-OH end of the single-stranded
gap could then initiate a recombination event via a
SDSA mechanism (40–42). Homology-dependent DNA
synthesis could then lead to the formation of a functional
supF gene. Thus, we speculate that pTFO-ICL-induced
GC may result predominantly from SDSA in these
substrates. Further studies are warranted to more com-
pletely elucidate the speciﬁc mechanism involved, since
increased understanding of this process will lead to more
eﬃcient gene targeting approaches.
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